Research graph
References from α-Boswellic acid alleviates atopic dermatitis via MME-mediated restoration of IL-18 BP/IL-18 axis homeostasis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.5826/dpc.1104a146
10.5826/dpc.1104a146 · External reference
Epidemiology and healthcare resource utilization in atopic dermatitis in Colombia: A retrospective analysis of data from the National Health Registry from 2015 to 2020
2023 · External reference
10.3390/ijms23126682
10.3390/ijms23126682 · External reference
10.3390/jcm11195633
10.3390/jcm11195633 · External reference
10.3390/cells10061392
10.3390/cells10061392 · External reference
10.3390/ijms221910381
10.3390/ijms221910381 · External reference
10.1111/bjd.21867
10.1111/bjd.21867 · External reference
10.3390/biom13040634
10.3390/biom13040634 · External reference
10.3389/fimmu.2023.955369
10.3389/fimmu.2023.955369 · External reference
10.3390/ijms252413505
10.3390/ijms252413505 · External reference
10.1111/all.15153
10.1111/all.15153 · External reference
10.3389/fimmu.2013.00289
10.3389/fimmu.2013.00289 · External reference
10.1007/s12079-019-00544-4
10.1007/s12079-019-00544-4 · External reference
10.3389/fimmu.2022.919973
10.3389/fimmu.2022.919973 · External reference
10.1016/j.sjbs.2019.09.019
10.1016/j.sjbs.2019.09.019 · External reference
10.3389/fphar.2023.1187181
10.3389/fphar.2023.1187181 · External reference
10.3389/fphar.2025.1692443
10.3389/fphar.2025.1692443 · External reference
10.1111/jop.13609
10.1111/jop.13609 · External reference
10.1007/s10787-025-01761-7
10.1007/s10787-025-01761-7 · External reference
10.1111/bph.16253
10.1111/bph.16253 · External reference
10.1016/j.intimp.2023.110958
10.1016/j.intimp.2023.110958 · External reference
10.1111/bph.15193
10.1111/bph.15193 · External reference
A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis
2014 · External reference
10.1186/s13073-022-01032-y
10.1186/s13073-022-01032-y · External reference
10.1038/s41586-023-05837-8
10.1038/s41586-023-05837-8 · External reference
10.1038/s41586-023-06742-w
10.1038/s41586-023-06742-w · External reference
10.4110/in.2024.24.e1
10.4110/in.2024.24.e1 · External reference
10.1016/j.jaci.2021.01.013
10.1016/j.jaci.2021.01.013 · External reference
10.1186/s13075-017-1505-8
10.1186/s13075-017-1505-8 · External reference
10.1016/j.immuni.2013.07.020
10.1016/j.immuni.2013.07.020 · External reference
10.1016/j.heliyon.2023.e23278
10.1016/j.heliyon.2023.e23278 · External reference
10.4049/jimmunol.1402583
10.4049/jimmunol.1402583 · External reference
10.3390/ijms20030649
10.3390/ijms20030649 · External reference
10.1159/000333006
10.1159/000333006 · External reference
10.1152/ajprenal.90524.2008
10.1152/ajprenal.90524.2008 · External reference
10.1074/jbc.m113.546309
10.1074/jbc.m113.546309 · External reference
10.1016/j.bbrc.2008.12.161
10.1016/j.bbrc.2008.12.161 · External reference
10.3233/jad-221026
10.3233/jad-221026 · External reference
10.1186/s13104-023-06291-5
10.1186/s13104-023-06291-5 · External reference
10.1007/s12672-025-02953-x
10.1007/s12672-025-02953-x · External reference
10.1007/s00580-025-03709-3
10.1007/s00580-025-03709-3 · External reference
10.1007/s00403-025-03955-z
10.1007/s00403-025-03955-z · External reference
10.15584/ejcem.2025.4.7
10.15584/ejcem.2025.4.7 · External reference
Mitigative effects of a topically-applied combination of cimifugin and vinpocetine on a murine psoriasis-like model
2025 · External reference
